Hymon® Urine Bladder Cancer Screening

Short Description:

HymonBio Bladder Cancer Gene Methylation Detection Kit is used to detect specific gene methylation of exfoliated cells in urine. This kit uses innovative multi-gene detection technology, combined with original NPC Nucleic Acid Extraction technology to better protect the integrity of cellular DNA and greatly improve sensitivity and specificity. The sensitivity was 92%, and the specificity was 94%. The kit uses non-invasive urine samples, making testing convenient and improves compliance, and providing a non-invasive technical means for monitoring recurrence after clinical treatment.

Send email to us

Product Detail

Product Tags

Technical Advantages

Multi-dimensional coverage: Detect 2 gene methylation markers

Magnetic bead extraction technology: Different-sized magnetic beads extract different lengths of nucleic acid for higher extraction rates

Patented MOLOCK antibody molecular lock amplification technology: Wild type gene is “locked” by antibody binding to prevent its amplification and ensures mutant gene amplification, increasing the detection rate from 1/100 to 1/10,000.

High sensitivity and specificity: 92% and 94% respectively

Detection Process

Application

High Risk Population:

Not suitable for cystoscopy, or when lesions cannot be determined by cystoscopy and imaging
Patients over 40 years of age with painless hematuria
Family history of bladder cancer
Poor diet and lack of exercise
Long-term occupational exposure to toxic chemical hazards

After treatment, gene methylation can be used to determine whether lesions have been completely removed.

Recurrence Surveillance: